Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

698 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Utilization of glucagon-like peptide-1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records database.
Hirose N, Tsujimoto N, Katayose T, Chin R. Hirose N, et al. Among authors: chin r. Diabetes Obes Metab. 2022 Mar;24(3):486-498. doi: 10.1111/dom.14600. Epub 2021 Dec 5. Diabetes Obes Metab. 2022. PMID: 34779098 Free PMC article.
Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial.
Kaku K, Haneda M, Sakamaki H, Yasui A, Murata T, Ustyugova A, Chin R, Hirase T, Shibahara T, Hayashi N, Kansal A, Kaspers S, Okamura T. Kaku K, et al. Among authors: chin r. Clin Ther. 2019 Oct;41(10):2021-2040.e11. doi: 10.1016/j.clinthera.2019.07.016. Epub 2019 Sep 25. Clin Ther. 2019. PMID: 31561882 Free article. Clinical Trial.
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial.
Kadowaki T, Chin R, Ozeki A, Imaoka T, Ogawa Y. Kadowaki T, et al. Among authors: chin r. Lancet Diabetes Endocrinol. 2022 Sep;10(9):634-644. doi: 10.1016/S2213-8587(22)00187-5. Epub 2022 Jul 30. Lancet Diabetes Endocrinol. 2022. PMID: 35914542 Clinical Trial.
Pharmacological PINK1 activation ameliorates Pathology in Parkinson's Disease models.
Hertz N, Chin R, Rakhit R, Ditsworth D, Wang C, Bartholomeus J, Liu S, Mody A, Laihsu A, Eastes A, Tai C, Kim R, Li J, Khasnavis S, Rafalski V, Heerendeen D, Garda V, Phung J, de Roulet D, Ordureau A, Harper JW, Johnstone S, Stöhr J. Hertz N, et al. Among authors: chin r. Res Sq [Preprint]. 2024 May 10:rs.3.rs-4356493. doi: 10.21203/rs.3.rs-4356493/v1. Res Sq. 2024. PMID: 38765977 Free PMC article. Preprint.
Autism spectrum disorder in children and young people with FND.
Simpson A, Tallur KK, Chin RFM, Yong K, Stone J. Simpson A, et al. Among authors: chin rfm. J Psychosom Res. 2024 Apr 21;182:111681. doi: 10.1016/j.jpsychores.2024.111681. Online ahead of print. J Psychosom Res. 2024. PMID: 38692183 No abstract available.
698 results